MLSS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
2.8M
+31.4%
2.2M
+5.1%
2.1M
-12.8%
2.4M
+1.6%
2.3M
Cost of Revenue
930.9K
+55.7%
598.0K
+7.5%
556.3K
-22.7%
719.2K
+1.9%
705.9K
Gross Profit
1.9M
+22.1%
1.6M
+4.2%
1.5M
-8.5%
1.6M
+1.4%
1.6M
Operating Expenses
3.0M
+24.2%
2.4M
-7.3%
2.6M
-7.0%
2.8M
-10.5%
3.1M
R&D
6.6K
0
-100.0%
12.3K
-24.0%
16.2K
-68.7%
51.8K
SG&A
2.9M
+24.1%
2.4M
-6.9%
2.5M
-6.9%
2.7M
-9.6%
3.0M
Operating Income
-1061563
-28.2%
-828083
+23.3%
-1079662
+4.8%
-1134471
+23.6%
-1484631
EBITDA
-1041974
-28.9%
-808629
+23.8%
-1060508
+4.8%
-1114367
+23.9%
-1465135
Net Income
-1059332
-26.1%
-839853
+23.0%
-1090561
+5.5%
-1153959
+22.2%
-1483110
EPS (Basic)
$-0.01
+0.0%
$-0.01
+0.0%
$-0.01
+0.0%
$-0.01
+50.0%
$-0.02
EPS (Diluted)
$-0.01
+0.0%
$-0.01
+0.0%
$-0.01
+0.0%
$-0.01
+50.0%
$-0.02
Shares (Diluted)
93.1M
+9.5%
85.0M
+3.7%
82.0M
-0.4%
82.3M
+0.3%
82.0M
Milestone Scientific (MLSS) โ€” Financials